Clinical Trial Update: The Safety, Tolerability, and Pharmacokinetic Study of SC1011 in Healthy Subjects. [Phase 1]

View source ↗

Summary

Phase 1 safety, tolerability, and pharmacokinetic study of SC1011 in healthy subjects has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Idiopathic Pulmonary Fibrosis
• Pulmonary Fibrosis

Drugs mentioned

• SC1011

Snippet

Sponsor: Guangzhou JOYO Pharma Co., Ltd | Conditions: Diopathic Pulmonary Fibrosis, Pulmonary Fibrosis | Phase 1 | Status: COMPLETED